Vertex Pharmaceuticals Inc (VRTX): $366.54
Market Cap: $96.31B
Enterprise Value: $85.81B
Vertex Pharmaceuticals (VRTX) is the longest-held position in our model portfolio, which is fascinating considering investing in biotech companies has always been out of our circle of competence. The company first came to our attention in November 2020 when an independ…